University of Michigan Rogel Cancer Center: Metformin May Reduce Afib After Ablation in Adults With Obesity
November 11, 2025
November 11, 2025
ANN ARBOR, Michigan, Nov. 11 -- The University of Michigan Rogel Cancer Center issued the following news release:
* * *
Metformin may reduce Afib after ablation in adults with obesity
Participants had Afib and obesity but not diabetes, for which the medication is commonly prescribed
Author: Noah Fromson, Public Relations Representative, fromsonn@med.umich.edu
Taking the diabetes medication metformin may reduce episodes of atrial f . . .
* * *
Metformin may reduce Afib after ablation in adults with obesity
Participants had Afib and obesity but not diabetes, for which the medication is commonly prescribed
Author: Noah Fromson, Public Relations Representative, fromsonn@med.umich.edu
Taking the diabetes medication metformin may reduce episodes of atrial f . . .
